Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Arcadia Biosciences, Inc. (RKDA : NSDQ)

• Company Description    Arcadia Biosciences Inc. is a producer and marketer of plant-based health and wellness products. Arcadia Biosciences Inc. is based in DALLAS. Number of Employees: 8

• Price / Volume Information    Yesterday's Closing Price: $0.64 Daily Weekly Monthly 20 Day Moving Average: 85,692 shares Shares Outstanding: 2.18 (millions) Market Capitalization: $1.40 (millions) Beta: 0.54 52 Week High: $5.72 52 Week Low: $0.59 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.19% -5.88% 12 Week -39.05% -40.72% Year To Date -67.68% -70.97%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5956 Sherry Lane Suite 2000 - Dallas,TX 75225 USA ph: 214-974-8921 fax: 530-756-7027 ir@arcadiabio.com http://www.arcadiabio.com

• General Corporate Information    Officers Thomas J. Schaefer - President; Chief Executive Officer Kevin Comcowich - Director Lilian Shackelford Murray - Director Gregory D. Waller - Director Amy Yoder - Director Peer Information Arcadia Biosciences, Inc. (CORR.) Arcadia Biosciences, Inc. (RSPI) Arcadia Biosciences, Inc. (CGXP) Arcadia Biosciences, Inc. (BGEN) Arcadia Biosciences, Inc. (GTBP) Arcadia Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 039014303 SIC: 1311 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 2.18 Most Recent Split Date: 3.00 (0.03:1) Beta: 0.54 Market Capitalization: $1.40 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.46 Price/Cash Flow: 0.50 Price / Sales: 0.29 EPS Growth vs. Year Ago Period: -211.05% vs. Previous Quarter: -115.31% Sales Growth vs. Year Ago Period: -8.33% vs. Previous Quarter: 22.09% ROE 06/30/26 - - 03/31/26 - -113.73 12/31/25 - 37.36 ROA 06/30/26 - - 03/31/26 - -68.47 12/31/25 - 23.95 Current Ratio 06/30/26 - - 03/31/26 - 3.79 12/31/25 - 3.09 Quick Ratio 06/30/26 - - 03/31/26 - 3.17 12/31/25 - 2.50 Operating Margin 06/30/26 - - 03/31/26 - -101.60 12/31/25 - 44.26 Net Margin 06/30/26 - - 03/31/26 - -195.94 12/31/25 - -48.15 Pre-Tax Margin 06/30/26 - - 03/31/26 - -195.78 12/31/25 - -47.98 Book Value 06/30/26 - - 03/31/26 - 1.40 12/31/25 - 2.39 Inventory Turnover 06/30/26 - - 03/31/26 - 2.49 12/31/25 - 2.28 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©